Publications
Specialty
Search
First Report Managed Care
10/16/2024
A study presented at AMCP Nexus 2024 reveals that most patients with Alzheimer disease are not expected to reach the new Medicare Part D out-of-pocket maximum of $2000, potentially hindering access to high-cost treatments like lecanemab.
First Report Managed Care
10/16/2024
Researchers at AMCP Nexus 2024 explored the cost-effectiveness of Midomafetamine-assisted therapy (MDMA-AT) for post-traumatic stress disorder (PTSD) in US health care settings, with findings suggesting it may be a more cost-effective treatment option than therapy alone.
The Dermatologist
10/16/2024
Collaboration and consideration are key to a successful medical intervention.
Psych Congress Network
10/16/2024
Monlunabant was associated with statistically significant weight loss, but the drug was also linked with mild to moderate neuropsychiatric side effects.
Psych Congress Network
10/16/2024
Christoph Correll, MD, provides a thorough pharmacological overview of the traditional and novel treatments available for schizophrenia.
IO Learning
10/16/2024
Nadine Abi-Jaoudeh, MD, discusses the drugs that interventional radiologists should be on the lookout for when treating patients with cancer.
Journal of Clinical Pathways
10/16/2024
A study presented at the 2024 ASCO Quality Care Symposium highlights gaps in palliative care access and education for patients with small cell lung cancer and their caregivers, emphasizing the urgent need for improved outreach and support in this vulnerable population.
Neurology
10/16/2024
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Oncology
10/16/2024
True or False: According to results from the phase 2, open-label ACE-536-MF-001 trial, luspatercept d
EMSWorld
10/16/2024
Ohio State and National Registry of EMTs research highlights the importance of the public’s help in opioid overdose response.
Cath Lab Digest
10/16/2024
Amanda Ryan, DO, an interventional cardiologist and owner of Advanced ASC of Carlsbad, New Mexico, shares her experience creating an ambulatory surgery center (ASC).
First Report Managed Care, Population Health
10/16/2024
As we approach the final stretch of the 2024 election, Medicare for All is once again part of the health care conversation. But here’s the reality: even some of its previous champions, like Vice President Kamala Harris, have moved on. Harris was a strong supporter of Medicare for All during her 2020 campaign, but as of recently, it’s no longer part of her platform.1 That’s because, when you dig deeper, it’s clear that this proposal is more of a campaign talking point than a practical solution to our health care challenges.
First Report Managed Care
10/15/2024
This study on the prescribing patterns of TV-46000 for schizophrenia treatment in the US reveals high persistence rates and frequent use as a first-line treatment option among patients.
First Report Managed Care
10/15/2024
A surge in GLP-1 drug use for weight management in the US has led to decreasing rates of sustained use and meaningful weight loss, as highlighted in a recent study analyzing trends in medication persistence and outcomes.
Oncology
10/15/2024
According to phase 3 results from the SIERRA trial, anti-CD45 radioconjugate 131I-apamistamab was well-tolerated and showed a higher durable complete remission rate than standard care among older patients with relapsed/refractory acute myeloid leukemia.
Oncology
10/15/2024
True or False: According to study results comparing a custom DNA sequencing panel de
Oncology
10/15/2024
Erin Wiedmeier-Nutor, MD, discusses study results that compare a custom DNA sequencing panel designed to detect prognostic copy number alterations and gene mutations with a fluorescence in situ hybridization panel among untreated patients with CLL.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
10/15/2024
WASHINGTON, DC — Four of the seven Medicare Administrative Contractors (MACs) released final local coverage determinations (LCD) for AI-Coronary Plaque Analysis (AI-CPA).
Neurology
10/15/2024
Corey Ratcliffe, PhD student, discusses the implications of high bias risk in clinical prediction models for epilepsy.
Today's Wound Clinic, Wound Care
10/15/2024
The proposed policies for calendar year 2025 impact payment for autologous blood-derived products used in wound healing and reimbursement for CTPs, as well as caretaker training services, prior authorization, and more.
Reimbursement Library From A to Z
Subscribe and never miss an article!
Today's Wound Clinic Newsletter
